documents: FDA-2020-N-2267-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-N-2267-0001 FDA FDA-2020-N-2267 Endo Pharmaceuticals, Inc.; Withdrawal of Approval of a New Drug Application for OPANA (Oxymorphone Hydrochloride) Extended-Release Tablets Notice Withdrawal 2020-12-23T05:00:00Z 2020 12 2020-12-23T05:00:00Z   2020-12-23T15:11:29Z 2020-28283 0 0 09000064849c0fe7

Links from other tables